By Professor Dedee Frances Murrell

Journal articles

Karakioulaki M; Dunn P; Murrell DF; Payne A; Schmidt E; Werth V; Yale M; Yamagami J; Aoki V; Borradori L; Caux F; Culton D; Daneshpazhooh M; De D; Fairley J; Hammers C; Hertl M; Holtsche M; Joly P; Koga H; Maverakis E; Mosam A; Pan M; Pincelli C; Saleh MA; Sinha AA; Solimani F; Sprecher E; Tasanen K; Tull TJ; Van Beek N; Vielmuth F; Yayli S; Patsatsi A, 2025, 'Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece', JID Innovations, 5, http://dx.doi.org/10.1016/j.xjidi.2024.100339

He A; Koszegi B; Uzun S; Bilgic A; Bozca BC; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Kakuta R; Takahashi H; Nery D; Mundin C; Ramirez-Quizon M; Culton D; McAlpine S; Johal J; Shulruf B; Stone JH; Murrell DF, 2025, 'Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy', Journal of the European Academy of Dermatology and Venereology, 39, pp. 340 - 349, http://dx.doi.org/10.1111/jdv.20149

Murrell DF, 2025, 'Body image disturbance has severe psychosocial impacts in patients suffering from autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 39, pp. 253 - 254, http://dx.doi.org/10.1111/jdv.20491

Werth VP; Murrell DF; Joly P; Ardeleanu M; Hultsch V, 2025, 'Bullous pemphigoid burden of disease, management and unmet therapeutic needs', Journal of the European Academy of Dermatology and Venereology, 39, pp. 290 - 300, http://dx.doi.org/10.1111/jdv.20313

Walter S; Murrell DF, 2025, 'Towards gender equity for all members of the academic dermatology community.', Clin Dermatol, http://dx.doi.org/10.1016/j.clindermatol.2025.01.004

Sarsam S; Koszegi BJ; Murrell DF, 2025, 'Colchicine as a treatment option for inherited epidermolysis bullosa.', Clin Exp Dermatol, http://dx.doi.org/10.1093/ced/llaf016

Walter S; Murrell DF; Pratama R; Kizny Gordon AE; McIver CJ, 2025, 'Assessment of a Real-Time PCR Assay for the Detection of Dermatophytosis by Sampling With an Adhesive Tape Technique', Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.14415

Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Murrell DF; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Salavastru C; Koumaki D; Suru A; Yordanova IA; Zemskov S; Tsymbaliuk R; Ostapko O; Augustin M; Abeni D; Szepietowski JC; Jemec GB, 2025, 'Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.17668

Haag C; Alexis A; Aoki V; Bissonnette R; Blauvelt A; Chovatiya R; Cork MJ; Danby SG; Eichenfield LF; Eyerich K; Gooderham M; Guttman-Yassky E; Hijnen DJ; Irvine AD; Katoh N; Murrell DF; Leshem YA; Levin AA; Vittrup I; Olydam JI; Orfali RL; Paller AS; Renert-Yuval Y; Rosmarin D; Silverberg JI; Thyssen JP; Ständer S; Stefanovic N; Todd G; Yu JD; Simpson EL, 2024, 'A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council', The British journal of dermatology, 192, pp. 135 - 143, http://dx.doi.org/10.1093/bjd/ljae342

Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D, 2024, '“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires', Italian Journal of Pediatrics, 50, http://dx.doi.org/10.1186/s13052-024-01657-2

Akbarialiabad H; Pasdar A; Murrell DF, 2024, 'Digital twins in dermatology, current status, and the road ahead', npj Digital Medicine, 7, http://dx.doi.org/10.1038/s41746-024-01220-7

Werth VP; Murrell DF; Joly P; Heck R; Orengo JM; Ardeleanu M; Hultsch V, 2024, 'Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)', Advances in Therapy, 41, pp. 4418 - 4432, http://dx.doi.org/10.1007/s12325-024-02992-w

Akbarialiabad H; Grant-Kels JM; Murrell DF, 2024, 'A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists', Clinics in Dermatology, 42, pp. 723 - 726, http://dx.doi.org/10.1016/j.clindermatol.2024.05.008

Kiritsi D; Schauer F; Gewert S; Reineker K; Reimer-Taschenbrecker A; Schwieger-Briel A; Ott H; Schmoor C; Grishina O; Murrell D; Stiller B; Zahn T; Nyström A; Bruckner-Tuderman L, 2024, 'Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial', eClinicalMedicine, 77, http://dx.doi.org/10.1016/j.eclinm.2024.102900

Rademaker M; Jarrett P; Murrell DF; Sinclair RD; Pasfield L; Poppelwell D; Shumack S, 2024, 'Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-being', Australasian Journal of Dermatology, 65, pp. e145 - e155, http://dx.doi.org/10.1111/ajd.14308

Bai H; Lin G; Kantor J; Elston D; Grant-Kels JM; Murrell DF; Murase JE, 2024, 'Dermatology Journal Advisory Boards and editorial independence', JAAD International, 16, pp. 224 - 236, http://dx.doi.org/10.1016/j.jdin.2023.08.001

Akbarialiabad H; Grant-Kels JM; Murrell DF, 2024, 'Letter to the editor in reply to “A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists”', Clinics in Dermatology, 42, pp. 526 - 527, http://dx.doi.org/10.1016/j.clindermatol.2024.07.002

Murrell DF; Caux F; Patsatsi A; Hagino O; Rudnicka L; Vassileva S; Uzun S; Ye J; Yen K; Arora P; Gourlay SG; Joly P; Werth VP, 2024, 'Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study', Journal of Investigative Dermatology, 144, pp. 1762 - 1771.e6, http://dx.doi.org/10.1016/j.jid.2024.02.023

Walter S; Murrell DF, 2024, 'Gender equity in academic dermatology: Problems aplenty, yet paths ahead', Journal of the European Academy of Dermatology and Venereology, 38, pp. 1504 - 1513, http://dx.doi.org/10.1111/jdv.20027

Murrell DF; Joly P; Werth VP; Ujiie H; Worm M; Mangold AR; Avetisova E; Maloney J; Laws E; Mortensen E; Dubost-Brama A; Shabbir A, 2024, 'Correction to: Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT (Advances in Therapy, (2024), 41, 7, (2991-3002), 10.1007/s12325-024-02810-3)', Advances in Therapy, 41, pp. 3014 - 3015, http://dx.doi.org/10.1007/s12325-024-02886-x

Caux F; Patsatsi A; Karakioulaki M; Antiga E; Baselga E; Borradori L; Caproni M; Cardones AR; Chandran NS; Dräger S; Drenovska K; Goebeler M; Günther C; Hofmann SC; Ioannides D; Joly P; Marinović B; Mariotti EB; Marzano AV; Morel KD; Murrell DF; Prost C; Sárdy M; Setterfield J; Skiljevic D; Uzun S; Vassileva S; Zambruno G; Schmidt E, 2024, 'S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology', Journal of the European Academy of Dermatology and Venereology, 38, pp. 1006 - 1023, http://dx.doi.org/10.1111/jdv.19880

Murrell DF; Daneshpazhooh M, 2024, 'Impairment of sexual function in patients with pemphigus', Journal of the European Academy of Dermatology and Venereology, 38, pp. 643 - 644, http://dx.doi.org/10.1111/jdv.19882

Navarrete-Dechent C; Ashique KT; Ingram JR; Rudnicka L; Gilaberte Y; Ring J; Murrell DF; Elston D; Thiers BH, 2024, 'The road to publication: Advice from journal editors', Journal of the American Academy of Dermatology, 90, pp. 707 - 710, http://dx.doi.org/10.1016/j.jaad.2023.11.038

Labbouz S; Khan S; Gohara M; Lucas J; Sarkar R; Murrell DF; Dodiuk-Gad RP, 2024, 'Meeting report: Women’s Dermatology Society Forum at the 25th World Congress of Dermatology, Singapore, 2023', International Journal of Women's Dermatology, 10, http://dx.doi.org/10.1097/JW9.0000000000000125

Stone C; Bertolotti A; Davey L; Murrell DF, 2024, 'Atypical fixed drug eruption in confetti due to paracetamol', Dermatologica Sinica, 42, pp. 160 - 161, http://dx.doi.org/10.4103/ds.DS-D-23-00161

Stone C; Bak G; Oh D; Zhao C; Venugopal S; Kumar K; Murrell DF, 2024, 'Environmental triggers of pemphigus vulgaris and bullous pemphigoid: a case control study', Frontiers in Medicine, 11, http://dx.doi.org/10.3389/fmed.2024.1441369

Zhou AE; Jain NP; Gronbeck C; Sloan B; Murrell DF; Grant-Kels JM, 2024, 'Ethics of publication mills and payment for guaranteed authorships', Journal of the American Academy of Dermatology, http://dx.doi.org/10.1016/j.jaad.2024.10.034

Murrell DF; Weinberg JM; Yamauchi PS; Abdelmaksoud A; Grabbe S; Goldust M, 2024, 'Predatory Conferences and Journals in Dermatology Are Black Widow Parties', Skinmed, 22, pp. 407 - 408

Wang MA; Wilson A; Boucher D; Johal JS; Rosenthal NK; Cowan T; Koszegi B; Lara Rivero AD; Daniel BS; Martin LK; Kern JS; Murrell DF, 2024, 'The development and validation of an investigator global assessment score for keratosis pilaris', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.20326

Koszegi B; Wilson A; Stone C; Satge F; Cowan TL; Murrell DF, 2023, 'Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab: A 30-month experience', Clinical and Experimental Dermatology, 48, pp. 1266 - 1269, http://dx.doi.org/10.1093/ced/llad215

Guttman-Yassky E; Bahadori L; Brooks L; Clark KL; Grindebacke H; Ho CN; Katial R; Pham TH; Walton C; Datto CJ, 2023, 'Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial', Journal of the European Academy of Dermatology and Venereology, 37, pp. e1211 - e1214, http://dx.doi.org/10.1111/jdv.19195

Kircik LH; Alonso-Llamazares J; Bhatia N; Bukhalo M; Devani AR; Draelos ZD; Dubois J; Gooderham MJ; Kempers SE; Lain E; Lee M; Moore A; Murrell DF; Papp KA; Pariser DM; Sinclair R; Zirwas M; Burnett P; Higham RC; Krupa D; Berk DR, 2023, 'Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study', British Journal of Dermatology, 189, pp. 392 - 399, http://dx.doi.org/10.1093/bjd/ljad182

Yale M; Dunn P; Strong R; Davies I; Gallu L; Joly P; Murrell DF; Werth VP; Payne AS, 2023, 'The Importance of Patient-Focused Drug Development in Pemphigus and Pemphigoid', Journal of Investigative Dermatology, 143, pp. 1868 - 1871, http://dx.doi.org/10.1016/j.jid.2023.03.1673

Wilson BN; Shah R; Sun MD; Diaz AF; Murrell DF; Murase JE, 2023, 'Evaluation of skin of color publication trends over the past 2 decades in the Journal of the American Academy of Dermatology', Journal of the American Academy of Dermatology, 89, pp. 614 - 616, http://dx.doi.org/10.1016/j.jaad.2023.05.036

Stone C; Sheriff T; Liang Y; Murrell DF, 2023, 'Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasis', JEADV Clinical Practice, 2, pp. 549 - 552, http://dx.doi.org/10.1002/jvc2.182

Singh S; Kirtschig G; Anchan VN; Chi CC; Taghipour K; Boyle RJ; Murrell DF, 2023, 'Interventions for bullous pemphigoid', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD002292.pub4

Wang MA; Wilson A; Murrell DF, 2023, 'A Review of the Scoring and Assessment of Keratosis Pilaris', Skin Appendage Disorders, 9, pp. 241 - 251, http://dx.doi.org/10.1159/000529487

Mosallaei D; Murrell DF; Grant-Kels JM, 2023, 'Dermatoethics: Nepotism in dermatology residencies', Journal of the American Academy of Dermatology, 89, pp. 193 - 194, http://dx.doi.org/10.1016/j.jaad.2022.01.011

Silverberg JI; Bissonnette R; Kircik L; Murrell DF; Selfridge A; Liu K; Ahluwalia G; Guttman-Yassky E, 2023, 'Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE)', Journal of the European Academy of Dermatology and Venereology, 37, pp. 1366 - 1374, http://dx.doi.org/10.1111/jdv.18914

Patel NJ; Jayne DRW; Merkel PA; Bekker P; Zhang Y; McDowell PJ; Johal J; Heaney LG; Murrell D; Stone MN; Yue H; Stone JH, 2023, 'The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial', The Lancet Rheumatology, 5, pp. e413 - e421, http://dx.doi.org/10.1016/S2665-9913(23)00131-5

Murrell D; L. Bruckner A; Sprecher E; Kiritsi D; Maher L; Cunningham T; Kern JS, 2023, 'BG04 Oleogel-S10 (birch triterpenes) in the treatment of epidermolysis bullosa wounds: 24-month efficacy and safety data from the EASE study', British Journal of Dermatology, 188, http://dx.doi.org/10.1093/bjd/ljad113.144

Teng J; Paller AS; Bruckner AL; Murrell DF; Mellerio JE; Bodemer C; Martinez AE; Lugo-Somolinos A; Sprecher E; Laimer M; Wally V; Chan YM; Lin SY; Spellman M; Bauer JW, 2023, 'Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial', Journal of Drugs in Dermatology, 22, pp. 599 - 604, http://dx.doi.org/10.36849/JDD.7108

Murrell DF; Teng JMC; Guenthner S; Marathe K; Kempers S; Eads K; Castelo-Soccio L; Mendelsohn AM; Raiz J; Bunick CG, 2023, 'Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis', Clinical and Experimental Dermatology, 48, pp. 623 - 630, http://dx.doi.org/10.1093/ced/llad033

Cowan TL; Ho G; Daniel BS; Murrell DF, 2023, 'Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemic', JAAD International, 11, pp. 33 - 34, http://dx.doi.org/10.1016/j.jdin.2022.03.016

Tada Y; Takeoka S; Spelman L; Murrell D; Wu J; Zoob P; Bosman K; Chu C-Y; Chung W-H, 2023, 'ISID0459 - Demographics, comorbidities and disease severity before dupilumab treatment initiation in Asian patients with atopic dermatitis', , http://dx.doi.org/10.26226/m.641999e770c3630019098d8e

Wang M; Murrell D; Wilson A; Daniel B; Daniel Lara Rivero A; Martin L; Johannes J, 2023, 'ISID0396 - A novel investigator global assessment score for the evaluation of keratosis pilaris', , http://dx.doi.org/10.26226/m.641999e460d56100127c27b2

Lee H; Cowan TL; Daniel BS; Murrell DF, 2023, 'A review of JAK and IL-23 inhibitors to treat vitiligo', Australasian Journal of Dermatology, 64, pp. 204 - 212, http://dx.doi.org/10.1111/ajd.14001

Johal JS; Cowan TL; Murrell DF, 2023, 'Evaluating the nature and prevalence of glucocorticoid-induced type 2 diabetes mellitus in patients with autoimmune bullous diseases', Clinical and Experimental Dermatology, 48, pp. 448 - 452, http://dx.doi.org/10.1093/ced/llac137

Johal J; Cowan T; BILGIC A; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Mundin C; Ramirez Quizon M; Kakuta R; Takahashi H; Wilson A; Zeng F; Murrell D; H. Stone J, 2023, 'ISID0390 - Examining the risk factors for worsened glucocorticoid morbidity in a prospective, multicentre, international study of patients with autoimmune blistering diseases.', , http://dx.doi.org/10.26226/m.641999e288811f001400fb3d

Wilson A; Tariq Khan M; Murrell DF, 2023, 'Median canaliform nail dystrophy in a 2-year-old boy: Case report and review of the literature', Pediatric Dermatology, 40, pp. 511 - 518, http://dx.doi.org/10.1111/pde.15181

Back to profile page